A Quantitative Structure-Activity Relationship Study on a Series of Selective Non-zinc Binding Inhibitors of MMP13

被引:0
|
作者
Singh, Prithvi [1 ]
机构
[1] SK Govt Coll, Dept Chem, Sikar 332001, India
关键词
Non-zinc binding inhibitors of MMP13; Combinatorial protocol in multiple linear regression (CP-MLR) analysis; Chemometric; 2D-descriptors; QSAR study; MATRIX-METALLOPROTEINASE INHIBITORS; CARBONIC-ANHYDRASE; CHELATING INHIBITORS; RECEPTOR LIGANDS; QSAR; DERIVATIVES; OPTIMIZATION; DESCRIPTORS; SULFONAMIDE; REGRESSION;
D O I
10.2174/157340641002140131162437
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two novel series of potent and selective matrix metalloproteinase (MMP) inhibitors, involving unique binding mode at the active site and not interacting with the catalytic zinc, were collectively investigated to quantify their inhibition actions in relation with chemometric descriptors. Significant correlations, between their MMP13 inhibition activity and 2D-descriptors, were obtained through the combinatorial protocol in multiple linear regression (CP-MLR) computational procedure. The derived bi-variant models, validated internally and externally, were able to account for 86.5% of variance in the observed MMP13 inhibition activities. The filtered descriptors, from CP-MLR, satisfactorily explained the biological phenomenon under investigation. However the descriptors, MPC10, N-075 and C-030 accounting, respectively, for molecular path (bond) count of order 10, the structural fragments CH-N-CH and N-CH-N of aromatic ring remained prime to address the MMP13 inhibition actions of the compounds. From the highest significant correlations, it appeared that the higher value of MPC10 and absence of these aromatic ring fragments, are conducive in further improvement of MMP13 inhibition activity of a compound. The partial least squares (PLS) analysis has further confirmed the dominance of the identified descriptors. In the analysis, two-components remained optimum for these descriptors which are able to explain 89.3% of variances. Applicability domain (AD) analysis revealed that the suggested models have acceptable predictability. All the compounds remained within the AD of the proposed models and were evaluated correctly. Based on the inferences drawn from the study, some new analogues were suggested for further exploration. Their predicted MMP13 inhibition activities were much higher than the highest active congener of the original series.
引用
收藏
页码:174 / 188
页数:15
相关论文
共 50 条
  • [1] Selective non zinc binding inhibitors of MMP13
    De Savi, Chris
    Morley, Andrew D.
    Ting, Attilla
    Nash, Ian
    Karabelas, Kostas
    Wood, Christine M.
    James, Michael
    Norris, Stephen J.
    Karoutchi, Galith
    Rankine, Neil
    Hamlin, Gordon
    MacFaul, Philip A.
    Ryan, David
    Baker, Sarah V.
    Hargreaves, David
    Gerhardt, Stefan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (14) : 4215 - 4219
  • [2] Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2
    De Savi, Chris
    Morley, Andrew D.
    Nash, Ian
    Karoutchi, Galith
    Page, Ken
    Ting, Attilla
    Gerhardt, Stefan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 271 - 277
  • [3] Kinetic characterization of 4,4′-biphenylsulfonamides as selective non-zinc binding MMP inhibitors
    Santamaria, Salvatore
    Nuti, Elisa
    Cercignani, Giovanni
    La Regina, Giuseppe
    Silvestri, Romano
    Supuran, Claudiu T.
    Rossello, Armando
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2015, 30 (06) : 947 - 954
  • [4] Calculation of binding free energies for non-zinc chelating pyrimidine dicarboxamide inhibitors with MMP-13
    Carrascal, Noel
    Rizzo, Robert C.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (01) : 47 - 50
  • [5] Quantitative structure-activity relationship study on antitumour activity of a series of flavonoids
    Wang, Wei-Xuan
    Si, Hongzong
    Zhang, Ziding
    MOLECULAR SIMULATION, 2012, 38 (01) : 38 - 44
  • [6] Quantitative structure-activity relationship study of histone deacetylase inhibitors
    Xie, AH
    Liao, CZ
    Li, BY
    Li, ZB
    Ning, ZQ
    Hu, WM
    Lu, XP
    Zhou, JJ
    Shi, LM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U555 - U555
  • [7] Quantitative Structure-Activity Relationship (QSAR) Study of a Series of Benzimidazole Derivatives as Inhibitors of Saccharomyces Cerevisiae
    Podunavac-Kuzmanovic, Sonja O.
    Cvetkovic, Dragoljub D.
    Jevric, Lidija R.
    Uzelac, Natasa J.
    ACTA CHIMICA SLOVENICA, 2013, 60 (01) : 26 - 33
  • [8] A quantitative structure-activity relationship study on a series of Na+, K+-ATPase inhibitors
    Gupta, SP
    Bagaria, P
    Kumaran, S
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2004, 19 (05) : 389 - 393
  • [9] A quantitative structure-activity relationship. (QSAR) study on a few series of potent, highly selective inhibitors of nitric oxide synthase
    Bharti, Vishwa Deepak
    Gupta, Satya P.
    Kumar, Harish
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2014, 51 (01): : 29 - 36
  • [10] Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis
    Song, Jiao
    Peng, Peng
    Chang, Jun
    Liu, Ming-Ming
    Yu, Jian-Ming
    Zhou, Lu
    Sun, Xun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (09) : 2174 - 2178